Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Insmed to Present at Two September Investor Conferences
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Geron to Present at the Cantor Fitzgerald Healthcare Conference
-
Rigel to Present at Cantor Fitzgerald Global Healthcare Conference
-
ArQule to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26, 2017
-
Agenus to Present at Two Healthcare Investor Conferences In September
-
PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference
-
Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference
-
miRagen Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
XOMA to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Mcewen Mining (MUX) Announces Bought Deal of $40.5M
-
McEwen Mining Announces Bought Deal of $40.5 Million
-
Puma Biotechnology to Present at Cantor Fitzgerald Healthcare Conference
-
Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
-
Heron Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cidara Therapeutics to Present at Two Upcoming Conferences
-
Aldeyra Therapeutics (ALDX) Plans Offering of Common Stock
-
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
Achaogen to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
IRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference
-
Cambrex to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
MiMedx to Present at Cantor Fitzgerald's Global Healthcare Conference
-
Nabriva (NBRV): Shares Up 100% On LEAP 1 Data - Cantor
-
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference
-
CryoLife to Present at Two Investor Conferences in September 2017
-
T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Intra-Cellular Therapies to Participate at Upcoming Investor Conferences
-
Gemphire to Present at Cantor Fitzgerald Global Healthcare Conference on September 26 in New York
-
CymaBay Therapeutics to Present at Two Investor Conferences
-
Aratana Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
-
PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Strongbridge Biopharma plc to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Lexicon Pharmaceuticals To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
-
Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference
-
RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
T2 Biosystems (TTOO) Prices 4.38M Common Stock Offering at $4/Share
-
T2 Biosystems Announces Pricing of Public Offering of Common Stock
-
Anthem (ANTM): Reiterating Buy After Recent Selloff - Cantor
-
Arrowhead Pharmaceuticals Corp (ARWR): Raising PT 100% After Analyst Day - Cantor
-
Snap Inc (SNAP) PT Raised to $17 at Cantor Fitzgerald, Monetization Upside "significant"
-
Cantor Fitzgerald Starts Dynavax Technologies (DVAX) at Overweight
-
Orchid Island Capital Announces September 2017 Monthly Dividend and August 31, 2017 RMBS Portfolio Characteristics
-
T2 Biosystems (TTOO) Plans Offering of Common Stock
-
T2 Biosystems Announces Proposed Public Offering of Common Stock
-
Glaukos Corporation (GKOS) PT Raised to $60 at Cantor Fitzgerald, "Could Own the Entire Glaucoma Market"
-
Health Insurance Innovations to Present at Cantor Fitzgerald Global Healthcare Conference in New York
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference

